Knivsta, Sweden

Mattias Jönsson


 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Mattias Jönsson

Introduction

Mattias Jönsson is a notable inventor based in Knivsta, Sweden, with a robust portfolio of four patents. His work primarily focuses on the development of pharmaceutical compounds that target various medical conditions. Through his innovative approaches, Jönsson has made significant contributions to medical science, particularly in the treatment of diseases associated with elevated levels of specific proteins.

Latest Patents

Among Jönsson's recent patents, he has developed phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines. These compounds are designed to address health conditions linked to heightened levels of CX3CR1 and/or CX3CL1. The patented compounds show promise in treating a wide array of ailments, including acute and chronic inflammation, eye, lung, skin, and joint diseases, as well as autoimmune disorders, cardiovascular issues, metabolic conditions, and several others such as cancer and mood disorders.

Career Highlights

Currently, Jönsson is affiliated with Kancera AB, where he continues to push the boundaries of innovation in pharmaceutical development. His expertise and dedication have led to significant advancements in the understanding and treatment of complex diseases, marking him as a prominent figure within the scientific community.

Collaborations

In his career, Jönsson has had the opportunity to collaborate with skilled professionals like Jan Vågberg and Elisabeth Olsson. These collaborations often lead to fruitful exchanges of ideas and joint effort in the development of innovative solutions within the medical field.

Conclusion

Mattias Jönsson stands out as a key contributor to the realm of pharmaceuticals, thanks to his inventive spirit and commitment to addressing critical health challenges. With his latest patents, he continues to pave the way for novel treatments that could potentially improve the quality of life for many individuals facing debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…